Kainos Laboratories Inc. logo

Kainos Laboratories Inc. (4556)

Delisted
12 Jun 2026
JPX JPX
¥
2,268. 00
0
0%
¥
5.35B Market Cap
- P/E Ratio
140% Div Yield
1,100 Volume
- Eps
¥ 2,268
Previous Close
Day Range
2,268 2,268
Year Range
1,204 2,284
Want to track 4556 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.

4556 Chart

Kainos Laboratories Inc. (4556) FAQ

What does "Delisted" mean?

Kainos Laboratories Inc. has been removed from the exchange and is no longer publicly traded.

What was the last recorded dividend?

The last recorded dividend was paid on Mar 30, 2026 in the amount of ¥32.00 per share.

How long did the company pay dividends?

The company did not have a dividend payment history.

Were there any stock splits?

No stock splits were recorded prior to delisting.

What was the last known trading price?

The stock last traded at ¥2,268.00 on Jun 12, 2026 before being delisted.

Kainos Laboratories Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Yukihiro Nagatsu CEO
JPX Exchange
JP3205650009 ISIN
Japan Country
133 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

KAINOS Laboratories, Inc., based in Tokyo, Japan, is a multifaceted company engaged in the development, manufacturing, marketing, distribution, and import/export of a wide array of products. Founded in 1975, originally operating under the name DOMS-IATRON Co., Ltd., it shifted its identity to its current name in the same year. The company’s diverse portfolio encompasses pharmaceuticals, diagnostic reagents, related chemical products, as well as physical and chemical measurement instruments, and medical supplies. Beyond healthcare and scientific markets, KAINOS Laboratories also extends its prowess into the nutrition supplements, foodstuff, animal feed, and related products sectors, establishing itself as a significant entity in both health and science sectors within Japan.

Products and Services

  • Aqua-auto Kainos CRE-IV Test Kit

    A cutting-edge liquid form creatinine measurement reagent kit compatible with a broad range of automatic analyzer systems. This product underscores KAINOS Laboratories’ capability in facilitating advanced biochemical clinical testing.

  • Aqua-auto Kainos ALB Test Kit

    A specialized liquid form reagent kit designed for clinical applications, emphasizing the company’s focus on delivering precise diagnostic tools to the healthcare sector.

  • Aqua-auto Kainos UN-II Test Kit

    This kit stands out for its efficiency in liquid urea nitrogen measurement, showcasing KAINOS Laboratories' commitment to supporting clinical laboratories with high-quality reagents.

  • FGF-23 ELISA Kit

    A two-site enzyme-linked immunosorbent assay kit tailored for the measurement of FGF-23 in serum, reflecting KAINOS Laboratories’ expertise in the niche domain of enzyme analysis.

  • Point of Care Testing Solutions
    • Swiftgene Norovirus GI/GII Kainos

      An innovative diagnostic tool for the detection of noroviruses, enhancing KAINOS Laboratories' influence in the area of infectious disease management through rapid testing.

    • Statmark FLUstick II

      A reliable testing solution for identifying type A and B influenza virus antigens, contributing to the global fight against influenza through fast and efficient diagnostics.

    • Statmark Strep A

      Designed for the detection of Group A beta-hemolytic streptococci, this product signifies KAINOS Laboratories’ dedication to broadening its portfolio in point-of-care diagnostic solutions.

Contact Information

Address: 38-18, Hongo 2-chome
Phone: 81 3 3816 4123